I

InventisBio Co Ltd
SSE:688382

Watchlist Manager
InventisBio Co Ltd
SSE:688382
Watchlist
Price: 28.33 CNY -2.18% Market Closed
Market Cap: 16.4B CNY

Wall Street
Price Targets

Price Targets Summary
InventisBio Co Ltd

Wall Street analysts forecast InventisBio Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InventisBio Co Ltd is 50.24 CNY with a low forecast of 49.74 CNY and a high forecast of 51.71 CNY.

Lowest
Price Target
49.74 CNY
76% Upside
Average
Price Target
50.24 CNY
77% Upside
Highest
Price Target
51.71 CNY
83% Upside
InventisBio Co Ltd Competitors:
Price Targets
002675
Yantai Dongcheng Biochemicals Co Ltd
30% Upside
URGN
Urogen Pharma Ltd
54% Upside
ACAD
ACADIA Pharmaceuticals Inc
10% Upside
ENTA
Enanta Pharmaceuticals Inc
19% Upside
IVVD
Invivyd Inc
189% Upside
CRBU
Caribou Biosciences Inc
588% Upside
KURN
Kuros Biosciences AG
27% Upside
ALEC
Alector Inc
38% Upside

Revenue
Forecast

Revenue Estimate
InventisBio Co Ltd

The compound annual growth rate of InventisBio Co Ltd's revenue for the next 3 years is 58%.

N/A
Past Growth
58%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InventisBio Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InventisBio Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InventisBio Co Ltd's stock price target?
Price Target
50.24 CNY

According to Wall Street analysts, the average 1-year price target for InventisBio Co Ltd is 50.24 CNY with a low forecast of 49.74 CNY and a high forecast of 51.71 CNY.

What is InventisBio Co Ltd's Revenue forecast?
Projected CAGR
58%

The compound annual growth rate of InventisBio Co Ltd's revenue for the next 3 years is 58%.

Back to Top